Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders

about

Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders

Item

http://www.wikidata.org/entity/Q42680423

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Interferon-free therapy with d ...... h inherited bleeding disorders

@en

Interferon-free therapy with d ...... h inherited bleeding disorders

@nl

type

Item

label

Interferon-free therapy with d ...... h inherited bleeding disorders

@en

Interferon-free therapy with d ...... h inherited bleeding disorders

@nl

prefLabel

Interferon-free therapy with d ...... h inherited bleeding disorders

@en

Interferon-free therapy with d ...... h inherited bleeding disorders

@nl

P1476

Interferon-free therapy with d ...... h inherited bleeding disorders

@en

P2093

Daisuke Mizushima

http://www.w3.org/2001/XMLSchema#string

Ei Kinai

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Gatanaga

http://www.w3.org/2001/XMLSchema#string

Katsuji Teruya

http://www.w3.org/2001/XMLSchema#string

Koji Watanabe

http://www.w3.org/2001/XMLSchema#string

Kunihisa Tsukada

http://www.w3.org/2001/XMLSchema#string

Masashi Mizokami

http://www.w3.org/2001/XMLSchema#string

Masaya Sugiyama

http://www.w3.org/2001/XMLSchema#string

Shinichi Oka

http://www.w3.org/2001/XMLSchema#string

Takahiro Aoki

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients.

Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts.

Raltegravir is a substrate for SLC22A6: a putative mechanism for the interaction between raltegravir and tenofovir

HIV/hepatitis C coinfection natural history and disease progression.

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.

Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection.

Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV

P304

e0186255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0186255

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Haruka Uemura

P577

2017-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29045448

http://www.w3.org/2001/XMLSchema#string

P932

5646795

http://www.w3.org/2001/XMLSchema#string